EP1322667A4 - Tumor necrosis factor receptors 6-alpha and 6-beta - Google Patents
Tumor necrosis factor receptors 6-alpha and 6-betaInfo
- Publication number
- EP1322667A4 EP1322667A4 EP01966151A EP01966151A EP1322667A4 EP 1322667 A4 EP1322667 A4 EP 1322667A4 EP 01966151 A EP01966151 A EP 01966151A EP 01966151 A EP01966151 A EP 01966151A EP 1322667 A4 EP1322667 A4 EP 1322667A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- beta
- alpha
- necrosis factor
- tumor necrosis
- factor receptors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22759800P | 2000-08-25 | 2000-08-25 | |
US227598P | 2000-08-25 | ||
US25213100P | 2000-11-21 | 2000-11-21 | |
US252131P | 2000-11-21 | ||
US30322401P | 2001-07-06 | 2001-07-06 | |
US303224P | 2001-07-06 | ||
PCT/US2001/026396 WO2002018622A2 (en) | 2000-08-25 | 2001-08-24 | TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1322667A2 EP1322667A2 (en) | 2003-07-02 |
EP1322667A4 true EP1322667A4 (en) | 2004-08-18 |
Family
ID=27397742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01966151A Withdrawn EP1322667A4 (en) | 2000-08-25 | 2001-08-24 | Tumor necrosis factor receptors 6-alpha and 6-beta |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1322667A4 (en) |
AU (1) | AU2001286688A1 (en) |
CA (1) | CA2420593A1 (en) |
WO (1) | WO2002018622A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3049778C (en) * | 2017-01-26 | 2024-06-18 | Oklahoma Medical Research Foundation | Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0399666A1 (en) * | 1989-04-29 | 1990-11-28 | Delta Biotechnology Limited | Fusion proteins containing N-terminal fragments of human serum albumin |
WO1993015199A1 (en) * | 1992-01-31 | 1993-08-05 | Rhone-Poulenc Rorer S.A. | Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
WO1997024445A1 (en) * | 1995-12-30 | 1997-07-10 | Delta Biotechnology Limited | Recombinant fusion proteins to growth hormone and serum albumin |
WO1998030694A2 (en) * | 1997-01-14 | 1998-07-16 | Human Genome Sciences, Inc. | TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885800A (en) * | 1997-02-04 | 1999-03-23 | Smithkline Beecham Corporation | DNA encoding tumor necrosis related receptor, TR4 |
ATE393222T1 (en) * | 1997-09-18 | 2008-05-15 | Genentech Inc | DCR3 POLYPEPTIDE, A TNFR HOMOLOGUE |
IL138626A0 (en) * | 1998-03-30 | 2001-10-31 | Lilly Co Eli | Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the receptor superfamily |
-
2001
- 2001-08-24 AU AU2001286688A patent/AU2001286688A1/en not_active Abandoned
- 2001-08-24 CA CA002420593A patent/CA2420593A1/en not_active Abandoned
- 2001-08-24 WO PCT/US2001/026396 patent/WO2002018622A2/en not_active Application Discontinuation
- 2001-08-24 EP EP01966151A patent/EP1322667A4/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0399666A1 (en) * | 1989-04-29 | 1990-11-28 | Delta Biotechnology Limited | Fusion proteins containing N-terminal fragments of human serum albumin |
WO1993015199A1 (en) * | 1992-01-31 | 1993-08-05 | Rhone-Poulenc Rorer S.A. | Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
WO1997024445A1 (en) * | 1995-12-30 | 1997-07-10 | Delta Biotechnology Limited | Recombinant fusion proteins to growth hormone and serum albumin |
WO1998030694A2 (en) * | 1997-01-14 | 1998-07-16 | Human Genome Sciences, Inc. | TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) |
Non-Patent Citations (1)
Title |
---|
SYED S ET AL: "Potent antithrombin activity and delayed clearance from the circulation characterize recombinant hirudin genetically fused to albumin", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, vol. 89, no. 9, 1 May 1997 (1997-05-01), pages 3243 - 3252, XP002130705, ISSN: 0006-4971 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002018622A2 (en) | 2002-03-07 |
AU2001286688A1 (en) | 2002-03-13 |
EP1322667A2 (en) | 2003-07-02 |
WO2002018622A3 (en) | 2002-08-29 |
CA2420593A1 (en) | 2002-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5945801A (en) | Opoid antagonist compositions and dosage forms | |
MXPA03006121A (en) | Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors. | |
IL153246A0 (en) | Substituted quinazoline derivatives and their use as inhibitors | |
IL150632A0 (en) | Corticotropin releasing factor antagonists | |
IL159275A0 (en) | Phenylsulfonyl-1, 3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
IL154131A0 (en) | Quinazoline derivatives | |
HK1082690A1 (en) | Tumor necrosis factor antagonists and their use in endometriosis | |
MXPA03009220A (en) | Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors. | |
AU2002359126A8 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
AU2002359123A8 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
EG22612A (en) | Pyrimidine compounds and their use | |
TWI318974B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic use | |
HUP0300005A3 (en) | Modified cytokines for use in cancer therapy | |
ZA200307306B (en) | Indolines, substituted in portion 6, and their use as kinase inhibitors. | |
EP1294949A4 (en) | Human tumor necrosis factor delta and epsilon | |
GB0002835D0 (en) | Drug resistance in cancer | |
EP1322667A4 (en) | Tumor necrosis factor receptors 6-alpha and 6-beta | |
GB0007530D0 (en) | Trityl-type compounds and their use | |
GB0021497D0 (en) | Compounds and their use | |
GB0018887D0 (en) | Compound and their therapeutic use | |
HK1065792A1 (en) | 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
GB0200843D0 (en) | Benzodioxinopyrroles their preparation and use | |
AU7660601A (en) | Pseudo-metalloproteins, their preparation and use | |
AU6884801A (en) | Therapeutic compounds and methods | |
GB0117048D0 (en) | Theoretical and quantum ethnopharmacological protein kinase C inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030312 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040702 |
|
17Q | First examination report despatched |
Effective date: 20050525 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20051005 |